Gender Differences in HIV Sexual Risk Behaviors Among Clients of Substance Use Disorder Treatment Programs in the U.S

Archives of Sexual Behavior
Yue PanDaniel J Feaster

Abstract

This study examined differences in sexual risk behaviors by gender and over time among 1281 patients (777 males and 504 females) from 12 community-based substance use disorder treatment programs throughout the United States participating in CTN-0032, a randomized control trial conducted within the National Drug Abuse Treatment Clinical Trials Network. Zero-inflated negative binomial and negative binomial models were used in the statistical analysis. Results indicated significant reductions in most types of sexual risk behaviors among substance users regardless of the intervention arms. There were also significant gender differences in sexual risk behaviors. Men (compared with women) reported more condomless sex acts with their non-primary partners (IRR = 1.80, 95 % CI 1.21-2.69) and condomless anal sex acts (IRR = 1.74, 95 % CI 1.11-2.72), but fewer condomless sex partners (IRR = 0.87, 95 % CI 0.77-0.99), condomless vaginal sex acts (IRR = 0.83, 95 % CI 0.69-1.00), and condomless sex acts within 2 h of using drugs or alcohol (IRR = 0.70, 95 % CI 0.53-0.90). Gender-specific intervention approaches are called for in substance use disorder treatment.

References

Aug 1, 1994·American Journal of Public Health·S TortuW R Davis
Feb 16, 1994·JAMA : the Journal of the American Medical Association·A L AvinsS B Hulley
May 1, 1997·Substance Use & Misuse·R FiorentineE Taylor
Sep 19, 1998·The American Journal of Drug and Alcohol Abuse·D Longshore, S Hsieh
Jul 1, 1999·The Psychiatric Clinics of North America·K T Brady, C L Randall
Aug 3, 1999·American Journal of Epidemiology·E VittinghoffS P Buchbinder
Mar 9, 2000·Drug and Alcohol Dependence·J L Sorensen, A L Copeland
Apr 12, 2000·Drug and Alcohol Dependence·R F RaschM L Dennis
Jun 27, 2000·Journal of Substance Abuse Treatment·G A Rowan-SzalD D Simpson
Apr 5, 2002·Journal of Substance Abuse Treatment·Richard A RawsonChris Reiber
Dec 11, 2003·Obstetrics and Gynecology Clinics of North America·Shelly F GreenfieldJessica E Nargiso
May 12, 2004·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Kara S RiehmanRicky N Bluthenthal
Oct 20, 2004·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Frank Y WongElin Begley
Jan 26, 2005·Sexually Transmitted Diseases·Carol A MetcalfUNKNOWN RESPECT-2 Study Group
Mar 4, 2006·AIDS·Beryl A KoblinSusan Buchbinder
Mar 17, 2007·The American Journal of Drug and Alcohol Abuse·Anita RajJeffrey H Samet
Jun 30, 2007·Journal of Sex Research·Kirk W ElifsonClaire E Sterk
Oct 8, 2008·Current HIV/AIDS Reports·David D CelentanoShruti H Mehta
Jan 20, 2009·Journal of Substance Abuse Treatment·Donald A CalsynSara B Berns
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Nicholas MeaderStephen Pilling
Jan 1, 2004·Multivariate Behavioral Research·David P MackinnonJason Williams
Apr 20, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David VlahovSteffanie A Strathdee
Nov 10, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·David S MetzgerCharles P O'Brien
Aug 23, 2011·The American Journal of Drug and Alcohol Abuse·Shelly F GreenfieldTheresa Winhusen
May 8, 2013·Journal of Consulting and Clinical Psychology·Gregory L StuartRyan C Shorey
Oct 15, 2013·Worldviews on Evidence-based Nursing·Victoria von SadovszkySamantha Boch
May 7, 2014·AIDS Research and Treatment·Patrice K NicholasShahnaz Moezzi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved